Ir para o conteúdo principal

Quanterix (NASDAQ: QTRX) — Perfil da empresa, notícias e dados financeiros

Logo de Quanterix
QTRX Quanterix
Quanterix  primary media
Perfil da empresa

Quanterix

Quanterix (NASDAQ:QTRX) specializes in providing high-definition diagnostics with a focus on developing technologies that enable deeper insights into disease biology. This capability allows for the detection and quantification of biomarkers at levels previously undetectable, a breakthrough with significant implications for medical research, diagnostics, and therapeutic development. The company's projects encompass a broad range of applications, from neurology and oncology to cardiology, aiming to revolutionize the approach to disease detection and monitoring. Quanterix's objectives include advancing precision health by empowering its customers with robust, scalable, and sensitive tools that enhance clinical outcomes and accelerate research and development in life sciences.

Resumo

Public USParticipação acionária
2007Ano de fundação
408Funcionários
Billercica, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
United States

Produtos e/ou serviços de Quanterix

  • Simoa HD-X Analyzer, an advanced ultrasensitive biomarker detection system enabling research in diagnostics and drug development.
  • Simoa Assay Kits, designed for precise measurement of biomolecules, critical for neurology and oncology research.
  • Homebrew Assay Development Kit, offering researchers the tools to develop custom assays for specialized biomarker detection.
  • Simoa Accelerator Lab, a service providing expertise in developing and running Simoa assays for biomarker research.
  • Neurology Research Solutions, focused on detecting neurological biomarkers to advance research in neurodegenerative diseases.
  • Oncology Research Solutions, aimed at improving cancer detection and research through ultra-sensitive biomarker analysis.

equipe executiva do Quanterix

  • William P. DonnellyExecutive Chair
  • David R. WaltCo-Founder & Chairman of Scientific Advisory Board
  • Everett V. CunninghamPresident, CEO & Director
  • Jason FaesslerCFO & Treasurer
  • Anthony CatalanoChief Operating Officer
  • Michael MillerChief Technology & Products Officer
  • Joshua YoungHead of Investor Relations
  • Daniel S. CharChief Legal Officer & Corporate Secretary
  • Erica BellChief People Officer
  • Naren BhatChief Strategy Officer

Principais indicadores financeiros

Resultados divulgados pela Quanterix , em USD.

Cap. de mercado
136,7 mi
Receita (TTM)
153,4 mi
P/L
—
LPA (diluído, TTM)
-2.6
Dividend yield
—
Margem de lucro
-80.3%
Receita e lucro anuais da Quanterix
Fim do ano fiscalReceitaResultado operacionalLucro líquido
138,7 mi-109,8 mi-107,2 mi
135,4 mi-52,6 mi-38,5 mi
121,1 mi-46 mi-28,4 mi
105,5 mi-104,3 mi-99,6 mi